Showing 381-387 of 387 for: Cochrane Systematic Reviews > Gynecologic 
- Uterine muscle relaxant drugs for threatened miscarriage
Cochrane Systematic Reviews, 20-Jul-2005
Miscarriage is the spontaneous loss of a pregnancy before the fetus is viable. Uterine muscle relaxant drugs have been used for women at risk of miscarriage in the belief they relax uterine muscle, and hence reduce the risk of miscarriage.
- Vaginal dilator therapy for women receiving pelvic radiotherapy
Cochrane Systematic Reviews, 8-Sep-2014
Vaginal dilation therapy is advocated after pelvic radiotherapy to prevent stenosis (abnormal narrowing of the vagina), but can be uncomfortable and psychologically distressing.
- Vasectomy occlusion techniques for male sterilization
Cochrane Systematic Reviews, 30-Mar-2014
Vasectomy is an increasingly popular and effective family planning method. A variety of vasectomy techniques are used worldwide, including vas occlusion techniques (excision and ligation, thermal or electrocautery, and mechanical and chemical occlusion me
- Vitamin D and vitamin D analogues for preventing fractures in post‐menopausal women and older men
Cochrane Systematic Reviews, 14-Apr-2014
Vitamin D and related compounds have been used to prevent osteoporotic fractures in older people. This is the third update of a Cochrane review first published in 1996.
- Vitamin supplementation for preventing miscarriage
Cochrane Systematic Reviews, 6-May-2016
Miscarriage is a common complication of pregnancy that can be caused by a wide range of factors. Poor dietary intake of vitamins has been associated with an increased risk of miscarriage, therefore supplementing women with vitamins either prior to or in e
- Volume expanders for the prevention of ovarian hyperstimulation syndrome
Cochrane Systematic Reviews, 31-Aug-2016
Ovarian hyperstimulation syndrome (OHSS) is a serious and potentially fatal complication of ovarian stimulation which affects 1% to 14% of all in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycles. A number of clinical studies wit
- Which anticholinergic drug for overactive bladder symptoms in adults
Cochrane Systematic Reviews, 18-Jan-2012
Around 16% to 45% of adults have overactive bladder symptoms, urgency with frequency or urgency urinary incontinence, or both, termed 'overactive bladder syndrome'. Anticholinergic drugs are common treatments.
